Profound Medical Corp.PROF
| Dec 31, 2020 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|
| Cash | - | - | - | 55 |
|---|
| Trade and other receivables, net (note 3) | - | - | - | 7 |
|---|
| Inventory, Net | - | - | - | 6 |
|---|
| Prepaid expenses and deposits | - | - | - | 1 |
|---|
| Total current assets | - | - | - | 69 |
|---|
| Property, Plant and Equipment, Net | - | - | - | 0 |
|---|
| Intangible assets, net (note 6) | - | - | - | 0 |
|---|
| Right-of-use assets, net (note 9) | - | - | - | 0 |
|---|
| Deferred Income Tax Assets, Net | - | - | - | 0 |
|---|
| Total assets | 105 | 64 | 44 | 70 |
|---|
| Accounts payable | - | - | - | 1 |
|---|
| Accrued Liabilities and Other Liabilities | - | - | - | 3 |
|---|
| Deferred revenue | - | - | - | 0 |
|---|
| Long-term debt (note 8) | - | - | - | 2 |
|---|
| Lease liabilities (note 9) | - | - | - | 0 |
|---|
| Total current liabilities | - | - | - | 7 |
|---|
| Deferred revenue | - | - | - | 0 |
|---|
| Long-term debt (note 8) | - | - | - | 3 |
|---|
| Lease liabilities (note 9) | - | - | - | 0 |
|---|
| Other Liabilities, Noncurrent | - | - | - | 0 |
|---|
| Total liabilities | 7 | 12 | 13 | 10 |
|---|
| Common Stock, Value, Issued | - | - | - | 282 |
|---|
| Additional paid-in capital | - | - | - | 21 |
|---|
| Accumulated other comprehensive income | - | - | - | 3 |
|---|
| Accumulated deficit | - | - | - | -245 |
|---|
| Total shareholders' equity | - | - | - | 60 |
|---|
| Total liabilities and shareholders' equity | - | - | - | 70 |
|---|